Aripiprazole: all 299 studies that test it
Page 2 of 3. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- Early Detection and Intervention for the Prevention of PsychosisCompletedNCT00531518Not applicableResults posted
- A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic SyndromeTerminatedNCT00508157Phase 4Results posted
- Aripiprazole Treatment for Methamphetamine Dependence Among High-risk IndividualsCompletedNCT00497055Phase 2Results posted
- Aripiprazole Augmentation of Antidepressants in PTSDCompletedNCT00489866Phase 2Results posted
- Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic ChildrenCompletedNCT00468130Not applicableResults posted
- Metabolic Signatures and Biomarkers in SchizophreniaCompletedNCT00466310Phase 1Results posted
- Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective DisorderCompletedNCT00423878Phase 4Results posted
- A Prospective Open-label Study of Aripiprazole in Fragile X SyndromeCompletedNCT00420459Phase 2Results posted
- Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-CompletedNCT00392197Phase 4Results posted
- Effects of Aripiprazole on Cocaine Craving and Self-AdministrationCompletedNCT00373880Phase 2Results posted
- Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)CompletedNCT00365859Phase 3Results posted
- A Placebo-Controlled, Cross-Over Trial of AripiprazoleCompletedNCT00351936Phase 4Results posted
- Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With SchizophreniaCompletedNCT00345033Phase 4Results posted
- Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)CompletedNCT00337571Phase 3Results posted
- Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).CompletedNCT00332241Phase 3Results posted
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode PsychosisCompletedNCT00320671Phase 4Results posted
- An Open-Label Trial of Aripiprazole in Autism Spectrum DisordersCompletedNCT00308074Phase 2Results posted
- Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic ChangesTerminatedNCT00288353Phase 3Results posted
- Treatment of Children With ADHD Who do Not Fully Respond to StimulantsTerminatedNCT00279409Phase 2Results posted
- A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed EpisodeCompletedNCT00277212Phase 4Results posted
- A Study of Aripiprazole (Abilify) in Patients With Bipolar ManiaCompletedNCT00261443Phase 4Results posted
- Trial of Aripiprazole in the Treatment of CD in AdolescentsCompletedNCT00250705Phase 4Results posted
- Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT00241176Phase 4Results posted
- Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical TrialsCompletedNCT00239356Phase 3Results posted
- 12- Week Open Label Treatment of Refractory Bipolar DepressionCompletedNCT00223496Phase 4Results posted
- Abilify as an Adjunctive Treatment for Refractory DepressionCompletedNCT00220636Phase 4Results posted
- The Effects of Aripiprazole on the Processing of Rewards in SchizophreniaTerminatedNCT00209027Not applicableResults posted
- Metabolic Effects of Antipsychotics in ChildrenCompletedNCT00205699Phase 4Results posted
- Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With AutismCompletedNCT00198107Phase 3Results posted
- Study of Aripiprazole (Abilify) in Children With Symptoms of ManiaCompletedNCT00194077Phase 3Results posted
- Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar DisorderCompletedNCT00194012Phase 3Results posted
- Aripiprazole in Children and Adolescents With Bipolar I DisorderCompletedNCT00110461Phase 3Results posted
- A Study of Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00105196Phase 3Results posted
- Aripiprazole Open-Label, Safety and Tolerability StudyCompletedNCT00102518Phase 3Results posted
- Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and AdolescentsCompletedNCT00102479Phase 1Results posted
- Aripiprazole in Adolescents With SchizophreniaCompletedNCT00102063Phase 3Results posted
- Switching Medication to Treat SchizophreniaCompletedNCT00044655Phase 4Results posted
- Neurobiological Mechanisms of Pathological Rumination and Effects of AripiprazoleActive, not recruitingNCT06937476Not applicable
- Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With SchizophreniaCompletedNCT06236451Phase 4
- Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)CompletedNCT05804721Phase 1
- Bioequivalence Study of Aripiprazole in Healthy Adult Subjects Under Fasting ConditionCompletedNCT05532254Phase 1
- RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)CompletedNCT05531591Phase 4
- The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of SchizophreniaCompletedNCT05322031Phase 4
- Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic HysterectomyCompletedNCT05103410Phase 4
- Clinical Efficacy and Change of Life Quality Through Using the Comprehensive Behavioral Intervention Treatment for TicsWithdrawnNCT04765085Not applicable
- Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model BuildingStatus unknownNCT04446234Phase 4
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-upStatus unknownNCT03883204Phase 4
- DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using AripiprazoleStatus unknownNCT03881449Phase 4
- A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I DisorderCompletedNCT03854409Phase 1
- Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia PatientsCompletedNCT03839251Phase 4
- Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia IndividualsStatus unknownNCT03790085Early Phase 1
- Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)CompletedNCT03510325Phase 3
- Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's SyndromeCompletedNCT03487783Phase 3
- Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic DisorderCompletedNCT03487770Phase 3
- Substance Misuse To Psychosis for StimulantsCompletedNCT03485417Phase 2/3
- MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical AntipsychoticsCompletedNCT03376763Phase 4
- Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World StudyCompletedNCT03289026Phase 4
- Aripiprazole IM Depot for Chinese Patients With SchizophreniaCompletedNCT03287505Phase 1
- PK Study of Aripiprazole IM Depot for Chinese Patients With SchizophreniaCompletedNCT03285503Phase 1
- Aripiprazole IM Depot in the Acute Treatment of Adults With SchizophreniaCompletedNCT03172871Phase 3
- Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With SchizophreniaCompletedNCT03150771Phase 1
- A Study of Diagnosis and Treatment of Depression Based on Biological Evidence of Dopamine Reward PathwayStatus unknownNCT03148509Phase 4
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-upStatus unknownNCT03090503Phase 4
- Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic ProfileCompletedNCT02949752Phase 4
- The Optimal Treatment for Treatment-resistant SchizophreniaStatus unknownNCT02926976Not applicable
- Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in SchCompletedNCT02697045Phase 4
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic TreatmentStatus unknownNCT02650102Phase 1/2
- A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective DisorderCompletedNCT02636842Phase 1
- Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or RisperidoneCompletedNCT02634463Phase 1
- Combination Treatment for Augmenting Language in Children With ASDCompletedNCT02574741Phase 2
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-upCompletedNCT02534363Phase 4
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-upStatus unknownNCT02532491Phase 4
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-upCompletedNCT02526030Phase 4
- Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy VolunteersCompletedNCT02501109Phase 1
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Pan European Collaboration on Antipsychotic Naïve Schizophrenia IICompletedNCT02339844Phase 4
- An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable SchizophreniaCompletedNCT02320032Phase 1
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective PsychosisCompletedNCT02305823Phase 4
- European Long-acting Antipsychotics in Schizophrenia TrialCompletedNCT02146547Phase 4
- Antipsychotic to Treat Psychosis SyndromeStatus unknownNCT02137616Not applicable
- Study to Evaluate the Efficacy and Safety of AripiprazoleStatus unknownNCT02069977Phase 4
- Adjunctive Aripiprazole in the Treatment of Risperidone-Induced HyperprolactinemiaStatus unknownNCT02013232Not applicable
- Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I DisorderWithdrawnNCT01981811Phase 2
- A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older AdultsWithdrawnNCT01942187Phase 4
- An Study of Aripiprazole in the Treatment of Methamphetamine DependenceTerminatedNCT01813656Phase 4
- A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated PsychosisTerminatedNCT01813643Phase 4
- Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective PsychosisStatus unknownNCT01765829Phase 3
- A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum DisordersStatus unknownNCT01742390Phase 4
- Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic SyndromeCompletedNCT01714011Phase 4
- Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders PatientsStatus unknownNCT01710163Phase 4
- Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive DisorderCompletedNCT01696617Phase 4
- Canadian Biomarker Integration Network for Depression StudyCompletedNCT01655706Phase 3
- A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five AntipsychoticsCompletedNCT01607762Phase 1
- Change in Brain Metabolism and Cognitive Function by AripiprazoleCompletedNCT01562808Not applicable
- Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot StudyTerminatedNCT01520350Phase 3
- A Study of ALKS 9072 in Subjects With Chronic Stable SchizophreniaCompletedNCT01493726Phase 1
- Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive DisorderStatus unknownNCT01488266Not applicable
- Bergen Psychosis Project 2 - The Best Intro StudyCompletedNCT01446328Phase 4
- Aripiprazole for the Augmentation of Antidepressant TherapyCompletedNCT01429831Phase 4
- A PET Study in Healthy VolunteersCompletedNCT01424449Phase 1